HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 88 filers reported holding HARROW HEALTH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,028,917 | +78237.9% | 280,370 | +15.3% | 0.00% | -33.3% |
| Q1 2023 | $5,143 | +130.0% | 243,067 | +60.4% | 0.00% | +200.0% |
| Q4 2022 | $2,236 | -99.8% | 151,503 | +51.8% | 0.00% | 0.0% |
| Q3 2022 | $1,205,000 | -18.2% | 99,814 | -50.7% | 0.00% | 0.0% |
| Q2 2022 | $1,473,000 | +9.0% | 202,396 | +2.1% | 0.00% | 0.0% |
| Q1 2022 | $1,351,000 | -24.1% | 198,139 | -3.8% | 0.00% | 0.0% |
| Q4 2021 | $1,779,000 | -19.6% | 205,925 | -15.5% | 0.00% | 0.0% |
| Q3 2021 | $2,214,000 | -36.4% | 243,585 | -35.0% | 0.00% | -50.0% |
| Q2 2021 | $3,482,000 | +1527.1% | 374,801 | +1082.7% | 0.00% | – |
| Q1 2021 | $214,000 | -71.0% | 31,690 | -70.6% | 0.00% | -100.0% |
| Q4 2020 | $739,000 | -26.8% | 107,742 | -59.2% | 0.00% | -50.0% |
| Q1 2020 | $1,010,000 | +337.2% | 264,368 | +895.4% | 0.00% | – |
| Q2 2019 | $231,000 | -78.4% | 26,559 | -87.6% | 0.00% | -100.0% |
| Q1 2019 | $1,067,000 | – | 214,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
| Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
| Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
| Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
| Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
| Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
| Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
| CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
| BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |